8-K: Axcelis Stockholders Approve Veeco Merger

Axcelis Technologies, Inc. stockholders overwhelmingly approved the share issuance proposal for the pending merger with Veeco Instruments Inc., moving the transaction closer to completion.

Summary

• Axcelis Technologies, Inc. held a Special Meeting of Stockholders on February 6, 2026, to vote on proposals related to its merger with Veeco Instruments Inc.
• As of the December 26, 2025 record date, 30,699,201 shares were outstanding and entitled to vote.
• A quorum was present with 25,228,112 shares, representing approximately 82.18% of the voting power, at the Special Meeting.
• The Share Issuance Proposal, requiring the affirmative vote of a majority of votes cast, was approved with 24,128,309 votes (95.84%) For and 1,048,205 votes (4.16%) Against.
• The Adjournment Proposal was also approved with 23,376,908 votes (92.86%) For, but was not necessary due to the approval of the Share Issuance Proposal.
• The merger remains subject to other customary closing conditions, including final regulatory approval from the State Administration for Market Regulation of the People's Republic of China.
• Axcelis and Veeco continue to expect the merger to be completed in the second half of 2026.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a highly positive development, as a major hurdle for the Axcelis-Veeco merger has been successfully cleared with overwhelming shareholder support, significantly de-risking the transaction's path forward.

Positives

• Stockholders overwhelmingly approved the Share Issuance Proposal with 95.84% of votes cast in favor, indicating strong support for the merger.
• The approval of the Share Issuance Proposal removes a significant condition precedent for the merger to proceed.
• The Adjournment Proposal, while approved, was not needed, demonstrating sufficient votes were secured for the primary merger proposal.

Negatives

• The merger is still subject to final regulatory approval from the State Administration for Market Regulation of the People's Republic of China, which remains a potential hurdle.

Risks

• Failure to obtain applicable regulatory approvals in a timely manner or otherwise.
• Failure to satisfy other closing conditions or to complete the proposed transaction on anticipated terms and timing.
• Negative effects from the announcement of the proposed transaction.
• Risks that the businesses will not be integrated successfully or that the combined company will not realize expected benefits, cost savings, accretion, synergies, and/or growth, or that such benefits may take longer or be more costly to achieve.
• Disruptions from the proposed transaction harming business plans and operations.
• Unanticipated costs of integration; significant transaction and/or integration costs, or difficulties in connection with the proposed transaction and/or unknown or inestimable liabilities.
• Restrictions during the pendency of the proposed transaction that may impact the ability to pursue certain business opportunities or strategic transactions.
• Potential litigation associated with the proposed transaction.
• Potential impact of the announcement or consummation of the proposed transaction on relationships with suppliers, customers, employees, and regulators.
• Demand for the combined company's products.
• Economic, political, and social conditions in countries where Axcelis and Veeco, their customers, and suppliers operate.
• Disruption to manufacturing facilities or operations due to natural catastrophic events, health epidemics, or terrorism.
• Ongoing changes in the technology and semiconductor industries, including growth rates, pricing trends, or changes in customer capital spending.
• Ability to timely develop new technologies and products that anticipate or address industry changes.
• Ability to maintain technology advantage and protect proprietary rights.
• Ability to compete with new products introduced by competitors.
• Ability of Axcelis, Veeco, or their customers to obtain U.S. export control licenses for sales or services to customers in China.

Future Outlook

The merger between Axcelis and Veeco is expected to be completed in the second half of 2026, pending the satisfaction of remaining customary closing conditions, most notably the final regulatory approval from the State Administration for Market Regulation of the People's Republic of China.

Industry Context

StockSavvy.ai notes that the semiconductor industry is undergoing significant consolidation and strategic realignments as companies seek to enhance their market position, expand technological capabilities, and achieve economies of scale. This merger between Axcelis, a leader in ion implantation systems, and Veeco, a provider of advanced process equipment, reflects a broader trend towards creating more comprehensive solutions for chip manufacturers, particularly in an environment of increasing demand for advanced wafer fabrication equipment. The focus on regulatory approval from China highlights the critical role of the Chinese market and its regulatory landscape in global semiconductor industry transactions.

Legal Proceedings

• Potential litigation associated with the proposed merger is listed as a risk factor.

Stakeholder Impact

• Shareholders: Axcelis shareholders approved the merger, indicating their support for the strategic direction and potential future value of the combined entity. Veeco shareholders will also be impacted by the merger.
• Employees: Risks include potential disruptions from the proposed transaction harming business plans and operations, and the potential impact on relationships with employees.
• Customers: Risks include the potential impact on relationships with customers and demand for the combined company's products.
• Suppliers: Risks include the potential impact on relationships with suppliers.
• Regulators: The merger is subject to regulatory approval, particularly from China, indicating ongoing engagement with regulatory bodies.

Next Steps

• Obtain final regulatory approval from the State Administration for Market Regulation of the People's Republic of China.
• Satisfy other customary closing conditions for the merger.
• Complete the merger in the second half of 2026.

Key Dates

Recommendation

The overwhelming shareholder approval of the merger proposals removes a significant layer of uncertainty and a key condition precedent for the Axcelis-Veeco transaction. This positive development de-risks the merger's completion, making the stock more attractive for investors who believe in the strategic rationale and potential synergies of the combined entity. While final regulatory approval from China is still pending, this filing indicates strong internal alignment and progress towards the anticipated second-half 2026 closing.

Keywords

Axcelis Technologies, Veeco Instruments, Merger, Acquisition, Shareholder Vote, SEC Filing, Semiconductor Industry, Ion Implantation, Wafer Fabrication Equipment, Regulatory Approval, China Market Regulation, ACLS, VECO